Literature DB >> 15654255

Functional characterization of prostate cancer by integrated magnetic resonance imaging and oxygenation changes during carbogen breathing.

Till Diergarten1, Petros Martirosian, Raimund Kottke, Ulrich Vogel, Arnulf Stenzl, Claus D Claussen, Heinz-Peter Schlemmer.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the changes in oxygenation of prostate cancer induced by carbogen breathing using blood oxygen level-dependent (BOLD) magnetic resonance image (MRI) with an endorectal coil (eMRI).
MATERIALS AND METHODS: In 32 patients with biopsy-proven prostate cancer, endorectal MRI was performed at 1.5 Tesla using the BOLD method. Images were acquired during 4 x 4-minute episodes alternating between room air and carbogen (95% O2/5% CO2) breathing. In each episode, 40 images were acquired (T2*-weighted EPI sequence, 12-14 slices, 3-mm thickness). All patients underwent radical prostatectomy; BOLD-MRI findings were correlated with the histopathologic results.
RESULTS: BOLD-MRI could be evaluated in 29 patients, and revealed heterogeneous signal changes of normal prostate and cancer tissue similar to the heterogeneity of prostate tissue in anatomic/pathologic preparation. A significant signal intensity increase (P = 0.004) was found in normal central gland and peripheral zone during carbogen breathing. Signal enhancement in carcinoma was significantly lower (P = 0.004) compared with the contralateral normal side.
CONCLUSION: Intrinsic blood-tissue contrast-functional MRI during carbogen breathing may help detect and characterize prostate carcinoma from normal tissue, particularly in small 1-sided carcinomas. This may be useful for identifying candidates for radiotherapy and monitoring noninvasive therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654255     DOI: 10.1097/01.rli.0000149490.59417.6e

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  7 in total

Review 1.  Image-based biomarkers in clinical practice.

Authors:  John E Bayouth; Thomas L Casavant; Michael M Graham; Milan Sonka; Manickam Muruganandham; John M Buatti
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

2.  Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T.

Authors:  Rami R Hallac; Yao Ding; Qing Yuan; Roderick W McColl; Jayanthi Lea; Robert D Sims; Paul T Weatherall; Ralph P Mason
Journal:  NMR Biomed       Date:  2012-05-23       Impact factor: 4.044

3.  Systematic protocol for assessment of the validity of BOLD MRI in a rabbit model of inflammatory arthritis at 1.5 tesla.

Authors:  Michael W Chan; George Nathanael; Antonella Kis; Afsaneh Amirabadi; Anguo Zhong; Tammy Rayner; Ruth Weiss; Garry Detzler; Roland Jong; Harpal Gahunia; Rahim Moineddin; Adrian Crawley; Andrea S Doria
Journal:  Pediatr Radiol       Date:  2013-12-24

4.  Hypofractionated Conformal Radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension : efficacy and toxicity.

Authors:  Maria Alessandra Mirri; Giorgio Arcangeli; Marcello Benassi; Annelisa d'Angelo; Valentina Pinzi; Mauro Caterino; Massimo Rinaldi; Anna Ceribelli; Lidia Strigari
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

Review 5.  High-field small animal magnetic resonance oncology studies.

Authors:  Louisa Bokacheva; Ellen Ackerstaff; H Carl LeKaye; Kristen Zakian; Jason A Koutcher
Journal:  Phys Med Biol       Date:  2013-12-30       Impact factor: 3.609

6.  Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer.

Authors:  Heling Zhou; Rami R Hallac; Qing Yuan; Yao Ding; Zhongwei Zhang; Xian-Jin Xie; Franto Francis; Claus G Roehrborn; R Douglas Sims; Daniel N Costa; Ganesh V Raj; Ralph P Mason
Journal:  Diagnostics (Basel)       Date:  2017-08-24

7.  Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience.

Authors:  Yongtae Kim; Jung Jae Park; Chan Kyo Kim
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.